文献速递脑血管病认知障碍与痴呆

多标志物脑小血管病评分与痴呆风险:Framingham心脏研究

Multimarker Cerebral Small Vessel Disease Score and Risk of Incident Dementia in the Framingham Heart Study.
PubMed 文献 · Neurology · 2025-09-15

基于Framingham心脏研究1152例>55岁无痴呆参与者,构建包含脑微出血、隐匿性脑梗死、广泛白质高信号、高负荷血管周围间隙和皮质表面铁沉积的多标志物CSVD评分。中位随访7.4年,评分≥2者全因痴呆风险显著升高(校正FSRP后HR 1.67;95%CI 1.05-2.66),模型区分度与FSRP相近(Harrell c-statistics 0.82-0.83)。

要点

  • 多标志物CSVD评分≥2与全因痴呆风险独立相关(校正FSRP后HR 1.67)。
  • 该评分对痴呆风险的预测区分度与FSRP相近(c-statistics 0.82-0.83)。
  • 结果支持将多标志物CSVD评分作为痴呆风险指标,但需外部验证。

核心结论

  • 多标志物CSVD评分与全因痴呆风险显著相关,且独立于FSRP及其各组分。
  • 该评分可能作为痴呆风险指标,预测区分度与FSRP相当。

研究设计与样本

  • Framingham心脏研究原始队列与子代队列的观察性队列分析,纳入1152例>55岁、MRI时无痴呆、卒中或其他神经系统疾病的参与者。
  • 多标志物CSVD评分定义为MRI检测到的脑微出血、隐匿性脑梗死、广泛白质高信号、高负荷血管周围间隙和皮质表面铁沉积之和。
  • 采用多变量Cox回归模型分析评分与全因痴呆、阿尔茨海默痴呆和血管性痴呆的关联。

主要发现

  • 参与者平均年龄70.9岁(SD 8.7),527例(46%)为男性,211例(18%)CSVD评分≥2。
  • 中位随访7.4年(四分位距4.6-11.3),评分≥2者较无CSVD标志物者全因痴呆风险显著升高(校正FSRP后HR 1.67;95%CI 1.05-2.66)。
  • 进一步校正血管危险因素后HR为1.76(95%CI 1.10-2.81)。
  • 多标志物CSVD评分的模型性能与FSRP相似(Harrell c-statistics 0.82-0.83)。

临床怎么用

  • 在临床痴呆风险评估中,可考虑整合多标志物CSVD评分以识别高风险个体。
  • 该评分可能提供独立于传统血管危险因素(FSRP)的额外风险信息。

局限性

  • 研究为观察性队列,需进一步研究验证多标志物CSVD评分在痴呆风险预测中的适用性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Individual MRI markers of cerebral small vessel disease (CSVD) are associated with impaired cognition and dementia but may not reflect the overall burden of CSVD. In addition, it is unclear whether these markers provide additional value in dementia risk assessment beyond vascular risk factors alone. Thus, we studied the association between the additive burden of multiple CSVD markers and incident dementia and determined whether this relationship remains independent of the Framingham Stroke Risk Profile (FSRP), a tool used commonly used for stroke risk prediction. METHODS: A total of 1,152 MRI scans from participants in the Original and Offspring cohorts of the Framingham Heart Study, a large observational cohort study, were included. Participants were older than 55 years and free of prevalent dementia, stroke, or other neurologic conditions at the time of MRI. A multimarker score capturing CSVD burden was defined as the sum of CSVD features detected in the MRI: cerebral microbleeds, covert brain infarcts, extensive white matter hyperintensities, high-burden perivascular spaces, and cortical superficial siderosis. Multivariate Cox regression models examined the association between the multimarker CSVD score and incident all-cause dementia, Alzheimer dementia (AD), and vascular dementia. RESULTS: The mean age was 70.9 years (SD 8.7) (527 [46%] were male), and 211 (18%) had a CSVD score of ≥2. Over a median follow-up time of 7.4 years (interquartile range 4.6-11.3), participants with a score ≥2 had significantly elevated risk of all-cause dementia compared with those with no CSVD markers after adjustment for the FSRP (hazard ratio [HR] 1.67; 95% CI 1.05-2.66) and vascular risk factors (HR 1.76; 95% CI 1.10-2.81). The multimarker CSVD score demonstrated similar model performance metrics to the FSRP (Harrell c-statistics 0.82-0.83). DISCUSSION: We found a significant association between all-cause dementia and multimarker CSVD scores, which was independent of the FSRP as well as its individual components. Our results support the use of a multimarker CSVD score as an indicator for incident all-cause dementia risk and suggest that it may be as robust as the FSRP. Further studies are necessary to validate the use of a multimarker CSVD score in dementia risk prediction.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Pinheiro A, Ekenze O, Aparicio HJ, et al. Multimarker Cerebral Small Vessel Disease Score and Risk of Incident Dementia in the Framingham Heart Study. Neurology. 2025. PMID: 40953349. doi:10.1212/WNL.0000000000214113

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。